Epitalon
Also known as: Epithalon, AEDG peptide
By GLPeptideSciences Editorial Team · How we evaluate evidence · Reviewed by Dr. George S. Watson, MD, Cardiothoracic Surgeon · Updated 2026-06-02
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied in longevity research, often in connection with the pineal peptide epithalamin and telomerase activity.
What it is & how it works
What it is
Epitalon is a synthetic tetrapeptide (the amino-acid sequence Ala-Glu-Asp-Gly). It was derived from research on epithalamin, a pineal-gland peptide preparation, and is discussed primarily in the longevity and circadian-rhythm context.
How it is thought to work
The proposed mechanisms center on pineal/melatonin regulation and, more controversially, telomerase activation (the enzyme that maintains telomere length). The telomerase angle is the source of most marketing claims.
The evidence gap
Much of the supportive data traces to a single research lineage and animal studies, with limited independent replication. Longevity outcomes are inherently hard to demonstrate in humans. Read lifespan and telomere claims with strong skepticism; reported sleep effects are anecdotal.
What it's discussed & studied for
- Cellular aging and healthspan (research interest)
- Sleep and circadian regulation (anecdotal)
Discussion of a use is not a claim that it works or is approved.
Research status
Early research, much of it from a single Russian research lineage; no large independent human trials confirming longevity effects.
Evidence quality
Low-to-mixed for the strongest claims. Telomerase and lifespan findings come largely from one research group and animal work; independent replication is limited.
Dosing discussion
Community protocols reference short cycles of subcutaneous microgram dosing once or twice a year. This is convention extrapolated from research, not validated guidance.
Educational summary of what is discussed in the literature and community — not a dosing recommendation or medical advice.
Safety & harm reduction
Limited long-term human safety data. As always, gray-market sourcing quality is a primary practical risk. Not FDA-approved.
Sourcing literacy
Claims around 'telomere lengthening' outrun the independent evidence — treat marketing skeptically and verify product identity and purity.
Selected literature
FAQ
Does Epitalon lengthen telomeres in humans?
That claim outpaces the independent evidence. Supportive findings come largely from one research lineage and preclinical work, without broad replication.
Is it approved?
No. It is not an approved therapy and is sold for research use only.